BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22706327)

  • 1. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
    Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
    Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
    Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
    Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
    McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
    Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
    Bentzley JP; Tomko RL; Gray KM
    J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
    Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
    Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
    Tomko RL; Gilmore AK; Gray KM
    Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
    Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
    Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents.
    McClure EA; Baker NL; Gray KM
    Am J Drug Alcohol Abuse; 2014 Jul; 40(4):285-91. PubMed ID: 24720376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
    Roten AT; Baker NL; Gray KM
    Addict Behav; 2013 Mar; 38(3):1788-91. PubMed ID: 23261493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.
    Freeman TP; Hindocha C; Baio G; Shaban NDC; Thomas EM; Astbury D; Freeman AM; Lees R; Craft S; Morrison PD; Bloomfield MAP; O'Ryan D; Kinghorn J; Morgan CJA; Mofeez A; Curran HV
    Lancet Psychiatry; 2020 Oct; 7(10):865-874. PubMed ID: 32735782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial.
    Herbst ED; Pennington DL; Borsari B; Manuel J; Yalch M; Alcid E; Martinez Rivas M; Delacruz J; Rossi N; Garcia B; Wong N; Batki SL
    Contemp Clin Trials; 2023 Aug; 131():107250. PubMed ID: 37271412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers.
    McClure EA; Wahlquist AE; Tomko RL; Baker NL; Carpenter MJ; Bradley ED; Cato PA; Gipson CD; Gray KM
    Drug Alcohol Depend; 2021 Aug; 225():108815. PubMed ID: 34171822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.
    McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM
    Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
    Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
    JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Brooks DJ; Pavlicova M; Cheng W; Nunes EV
    Drug Alcohol Depend; 2011 Jul; 116(1-3):142-50. PubMed ID: 21310551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
    Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial.
    McRae-Clark AL; Gray KM; Baker NL; Sherman BJ; Squeglia L; Sahlem GL; Wagner A; Tomko R
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109111. PubMed ID: 34655945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking note of over-the-counter remedies for adolescents with cannabis dependence.
    Bukstein OG
    Am J Psychiatry; 2012 Aug; 169(8):771-3. PubMed ID: 22854924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.